AGP Executive Report
Last update: 2 hours agoAI Safety & Policy: AI lab leaders and regulators are pushing for faster testing and evaluation as frontier models show “unexpected or concerning” behavior, with calls to slow development colliding with the race to deploy. Health Tech & Biotech: A personalized neoantigen vaccine for HPV-negative head and neck cancer showed encouraging activity with no dose-limiting toxicities in early trial results, while new cancer immunology work explains how p53-mutant tumors hide from T cells and suggests a way to “turn cold” tumors “hot.” Neuroscience: Researchers identify a brain region that sustains fear-driven behavior beyond the initial threat signal, and separate work shows how visual areas rapidly agree or discard conflicting inputs. Data, Deals & Compliance: Life sciences dealmaking is increasingly about who owns and can use data as AI accelerates discovery, and the FDA issued updated rules to expand non-animal testing options. Industry & Infrastructure: A $280,000 grant will expand hands-on fiber-optic training for regional schools to support AI-driven broadband and data centers; Germany released an engineering shortage list for EU Blue Card and Chancenkarte. Climate & Energy: World Ventilation Day spotlights overheating solutions, while the US EPA moves to loosen fossil power pollution limits. Business & Ethics: Reports say DraftKings used AI to target promotions at gamblers most likely to lose, raising concerns about addiction risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
